Citadel Advisors’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.91M | Buy |
2,889,760
+1,075,286
| +59% | +$3.69M | ﹤0.01% | 1370 |
|
|
2025
Q1 | $4.05M | Buy |
1,814,474
+1,217,223
| +204% | +$2.71M | ﹤0.01% | 1936 |
|
|
2024
Q4 | $1.75M | Sell |
597,251
-902,389
| -60% | -$2.64M | ﹤0.01% | 2737 |
|
|
2024
Q3 | $3.9M | Buy |
1,499,640
+26,430
| +2% | +$68.7K | ﹤0.01% | 1965 |
|
|
2024
Q2 | $4.36M | Buy |
1,473,210
+708,377
| +93% | +$2.1M | ﹤0.01% | 1787 |
|
|
2024
Q1 | $3.46M | Buy |
764,833
+186,527
| +32% | +$845K | ﹤0.01% | 2043 |
|
|
2023
Q4 | $3.3M | Sell |
578,306
-171,425
| -23% | -$979K | ﹤0.01% | 1982 |
|
|
2023
Q3 | $3.45M | Sell |
749,731
-1,444,039
| -66% | -$6.64M | ﹤0.01% | 1923 |
|
|
2023
Q2 | $14.2M | Buy |
2,193,770
+719,890
| +49% | +$4.65M | ﹤0.01% | 992 |
|
|
2023
Q1 | $11.1M | Buy |
1,473,880
+8,884
| +0.6% | +$67K | ﹤0.01% | 1242 |
|
|
2022
Q4 | $14.8M | Buy |
1,464,996
+968,448
| +195% | +$9.81M | ﹤0.01% | 1046 |
|
|
2022
Q3 | $4.91M | Buy |
496,548
+329,348
| +197% | +$3.26M | ﹤0.01% | 1875 |
|
|
2022
Q2 | $1.78M | Sell |
167,200
-1,942
| -1% | -$20.7K | ﹤0.01% | 2859 |
|
|
2022
Q1 | $1.65M | Sell |
169,142
-248,948
| -60% | -$2.43M | ﹤0.01% | 3225 |
|
|
2021
Q4 | $5.98M | Buy |
418,090
+57,471
| +16% | +$822K | ﹤0.01% | 1946 |
|
|
2021
Q3 | $7.23M | Sell |
360,619
-42,990
| -11% | -$862K | ﹤0.01% | 1733 |
|
|
2021
Q2 | $8.88M | Buy |
403,609
+263,034
| +187% | +$5.79M | ﹤0.01% | 1542 |
|
|
2021
Q1 | $4.77M | Sell |
140,575
-291,782
| -67% | -$9.91M | ﹤0.01% | 2158 |
|
|
2020
Q4 | $17.4M | Buy |
+432,357
| New | +$17.4M | ﹤0.01% | 931 |
|